[PDF] Top 20 Multiple myeloma cancer stem cells

... The Wnt signaling pathway plays a significant role in the regulation of cell proliferation, cell development and the differentiation of normal stem cells. Constitutive activation of Wnt signaling pathway is ... See full document

... normal stem cells or normal somatic cells into malignant ...Maintaining stem cells with their special properties is critical and ...keeping stem cells of intracellular ... See full document

... mononuclear cells (BMMC) and myeloma cell lines using the RNeasy Mini kit (Qiagen, Hilden, Germany) and reverse transcribed to complementary DNA (cDNA) applying avian myelo- blastosis virus (AMV) reverse ... See full document

... blood stem-cell transplantation are standards of therapy for patients diagnosed with multiple ...residual myeloma cells could improve patient out- ...human multiple myeloma ... See full document

... of multiple genes involved in cell adhesion and structural integrity of the skin (ICAM, CDHs, PERP, FRAS1), apoptosis (CASP10, BAX, APAF1, BAD, IER3), transcription (c-Jun, ZEB1, EGR3), cell cycle regulation (p21 ... See full document

... plasma cells in bone ...plasma cells which accounted for 14% of nucleated cells, and 3% immature plasma cells (Figure ...plasma cells disseminated in the bone marrow, which suggested ... See full document

... namely, Multiple Myeloma, a cancer of plasma cells that create excess monoclonal antibody; and kidney transplants, where the immune system produces polygonal antibodies against the implanted ... See full document

... Materials and methods: The subjects included two groups of patients with malignant lym- phoma and multiple myeloma. All patients received chemotherapy priming for the mobilization of PBSCs. All patients ... See full document

... daughter cells during cell division. As a result, cells progressively lose the dye as these non-CSC cells proliferate and divide ...CSCs cells maintain the fluorescence dye owing to lack of ... See full document

... plasma cells and serum- free light chains ratio of ≥100, or presence of >1focal lesion on MRI are also added in treatment indications (myeloma related ...disease, stem cell transplant eligibility, ... See full document

... In the past 20 years, the overall treatment for MM patients suitable for transplant had made great progress. Patients with treatment indica- tions will be recommended with induction treat- ment combined with three kinds ... See full document

... MM cells: the tyrosine kinase inhibitors (TKI) bosutinib, dasatinib, imatinib, sorafenib, sunitinib, and nilotinib, the ErbB-receptor inhibitors lapatinib, erlotinib, and gefitinib, the Aurora- kinase inhibitor ... See full document

... tumor cells. Tumor dormancy has been rec- ognized in AML, CML and breast cancer, where circu- lating or residual tumor cells are detected though complete remission by clinical standards has been dem- ... See full document

... autologous stem cells that reached a maximum VWF activity within 2 weeks after ASCT, a critical phase where therapy- related thrombocytopenia causes a high risk for spontaneous bleeding events ... See full document

... plasma cells in soft ...with multiple myeloma or related monoclonal disorders ...spleen cells of mineral oil-primed BALB/c ...of myeloma colonies was proportional to the number of ... See full document

... Stem cell transplantation Conditioning regimen Autologous stem cell collection Patient Thaw + transplant Autologous Freeze Stem Cells?. First-Line Therapy: Multiple Myeloma.[r] ... See full document

... CD34+ stem cells and differentiate along the myeloid ...endothelial cells and various tissue factors via adhesion ...as stem-cell factor (SCF) and interleukin-3 (IL-3), and to numerous ... See full document

... MM cells [34], points to MMSCs as the Achilles heel of current ...in myeloma: crosstalk between canonical and non- canonical signaling pathways in myeloma cells and microenvironment that ... See full document

... these cells disappeared within 3 to 5 weeks ...bystander cells, although proof of such evanescence is thus far not well defined ...mesenchymal cells exert similar therapeutic effects in SCID-rab mice ... See full document

... Multiple myeloma is the second most frequent hemato- logic malignancy responsible for about 86,000 new cases worldwide each year ...plasma cells in the bone marrow (more than 10%), pres- ence of ... See full document